Massive Profits For Covid19 Vaccine Plays?
How profitable will Covid19 vaccines be when all is said and done? One analyst thinks successful concerns will split $100 billion with a B in sales and $40 billion in profits
COVID-19 vaccine players will split $100B in sales and $40B in profits, with Moderna leading the way: analyst
Evercore ISI expects Moderna and Novavax to claim more than half of the market for COVID-19 vaccines, but the firm's predictions of how profitable their efforts will be are raising some eyebrows among investors. Factor in unknowns, like the number of doses needed for protection, and it becomes that much harder to place valuations on vaccine developers, they said.